Subscribe

Nomogram of Pond et al for Predicting a Serious Adverse Event During Cycle One of a Phase II Clinical Trial for a Molecularly Targeted Agent

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Pond et al developed a nomogram for predicting the odds ratio of a serious adverse event during cycle one of a Phase II clinical trial using a molecularly targeted agent. The authors are from Princess Margaret Hospital and University of Toronto (Princess Margaret Hospital Phase II Consortium).

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone